Bookmark list

Subscribe to newsletter

Sequenom and SensiGen Expand Global Alliance

04-Aug-2008

Protection for Antibodies and Antigens Coated on Plates

MolYsis: Selective Enrichment and Isolation of Bacterial and Fungal DNA from Host Material

High-performance chromatography columns for pilot projects

Sequenom, Inc. and SensiGen LLC, a privately held biotechnology company focused on developing proprietary gene-based, molecular diagnostic tests, announced expansion of their global alliance to develop and market advanced diagnostic tests and systems to commercial laboratories worldwide.

Under the expanded agreement, in addition to commercializing SensiGen's advanced test for human papillomavirus (HPV) exclusively on Sequenom's MassARRAY(R) platform, SensiGen will also be the exclusive provider of MassARRAY platform-based assays for SensiGen's newly developed Chronic Kidney Disease (CKD) and Lupus tests. Sequenom will exclusively supply platform technology and reagents used for commercializing SensiGen's proprietary tests. The expanded agreement also provides Sequenom with the future right to a minority equity interest in SensiGen. Financial terms of the alliance were not disclosed.

https://www.bionity.com/en/news/85351/sequenom-and-sensigen-expand-global-alliance.html

analytica 2024 presents the laboratory world of tomorrow

Focus topics are digitization and sustainability

Get the life science industry in your inbox

Sequenom and SensiGen Expand Global Alliance

analytica 2024 presents the laboratory world of tomorrow

Other news from the department business & finance

Merck Acquires JSR Chromatography Business

Novartis agrees to acquire Excellergy, Inc.

Growth in visitor numbers, full halls, clear future topics: analytica 2026 sets standards

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

Berlin names Health Innovation Quarter Berlin-Mitte the new place of the future

US pharmaceutical company Merck is acquiring Terns Pharmaceuticals for around $6.7 billion

Rentschler Biopharma completes the largest expansion in the company’s history in the US

Evonik shortens the path from research to market readinessEvonik launches Innovation Factory

VTU Engineering Germany gets new managing director

German analysis and laboratory industry cautiously optimistic about the current year

Automation and robotics drive growth in the laboratory

Roche launches AI initiative to tackle lengthy development times

Sartorius is counting on a biopharma boom by 2030

Biotech start-up secures €23 million total for cancer and infectious disease platform

German biotech company chooses Saxony-Anhalt for protein production facility

Nine million euros for innovative cancer therapy

Tecan aims to bring unused lab data to life with NVIDIA

Start-up AveThera acquires Fraunhofer site for biologics production

Chemicals still in trouble

​​​3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026

These products might interest you

Micro-Dx™ CE IVD by Molzym

Fully automated from sample to PCR analysis

FectoVIR®-AAV by Sartorius

Industrial-Scale rAAV Manufacturing with Enhanced Productivity and GMP Compliance

DNA-free Taq Polymerases and Mastermixes by Molzym

DNA-free reagents for unrivalled sensitivity in molecular biology

Blotting standards and reagents by Cytiva

Western blotting standards and reagents

Recombumin® Elite by Sartorius

ICHQ7 cGMP-compliant albumin for biotechnological applications

CellGenix® Growth Factors and Cytokines by Sartorius

Recombinant growth factors without animal products

Greener Alternative Products by Merck

Sustainable laboratory products for environmentally conscious research

Get the life science industry in your inbox

Most read news

Start-up AveThera acquires Fraunhofer site for biologics production

BioNTech co-founders establish new biotech company

Plastic bottles turned into Parkinson’s medication

More meat, lower risk of dementia: study reveals gene-dependent effect

How old are we really?

Already approved drug is effective against aggressive brain tumors

Roche grows against the trend and invests over 700 million euros in Germany

Disastrous interplay: protein uncovered that makes cancer grow faster

Failed experiment by Cambridge scientists leads to surprise drug development breakthrough

Roche launches AI initiative to tackle lengthy development times

Contraception without hormones: Research alternatives to “the pill”

Vascular killer LDL cholesterol: are butter, eggs and cheese the culprits?

More news from our other portals

AI rebuilds molecules from exploding fragments

German food tech company secures €8 million to combat food waste

Non-destructive battery testing: New method developed

A flexible electrolyte for solid batteries

Amazonian cocoa could become a superfood

Chemical industry at a turning point: six keys to transformation

Why does oat milk sometimes foam perfectly and sometimes not at all?

WACKER cuts over 1,500 jobs to reduce costs by €300 million

How climate-friendly is insect protein really?

How a 270-year-old physics trick could supercharge affordable battery technology

How can startups revolutionize home cooking?

How are 360,000 tons of used batteries per year turned into a treasure trove of raw materials?

Research team achieves breakthrough in breeding winter-hardy faba beans

CO2 to E-Methanol, Aviation Fuels and Speciality Chemicals

BAM, HZB and HU are conducting joint research on sodium batteries

Tailor-made New Battery Materials

Energy storage breakthrough solves the fast-charging problem

Last viewed contents

Research hope for bladder cancer

Dr. Reckeweg & Co GmbH - Bensheim, Germany

Analytical Sales and Services, Inc. - Pompton Plains, USA

The future of crop engineering - Scientists want to increase the efficiency of photosynthesis

3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026